title: [New guidelines for NAFLD – a Swedish perspective].
abstract: New guidelines for NAFLD - a Swedish perspective Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease globally, with an estimated prevalence of 25%. It is clinically challenging to identify which persons with known or suspected NAFLD that have the highest risk for development of severe liver disease. New guidelines from several European organizations were recently presented. The suggested changes to healthcare practice include screening of high-risk groups in order to identify cases with cirrhosis. These guidelines and suggestions for adjustments to Swedish healthcare are discussed.
authors.affiliation: Gastrocentrum, Karolinska Universitetssjukhuset - Stockholm, Sweden - Gastrocentrum Stockholm, Sweden.
authors.forename: Hannes
authors.initials: H
authors.lastname: Hagström
authors.affiliation: Karolinska Institutet - Endokrinkliniken, Karolinska Universitetssjukhuset Stockholm, Sweden Karolinska Institutet - Endokrinkliniken, Karolinska Universitetssjukhuset Stockholm, Sweden.
authors.forename: Johan
authors.initials: J
authors.lastname: Hoffstedt
authors.affiliation: Karolinska Institutet - Överviktscentrum, Karolinska Universitetssjukhuset Stockholm, Sweden Karolinska Institutet - Överviktscentrum, Karolinska Universitetssjukhuset Stockholm, Sweden.
authors.forename: Signy
authors.initials: S
authors.lastname: Reynisdottir
mesh_terms: D042241:Early Diagnosis; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis* / Q000209:etiology; D065626:Non-alcoholic Fatty Liver Disease / Q000150:complications / Q000175:diagnosis*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment / Q000379:methods*; D013548:Sweden